NextCure, Inc. (NXTC)
5.34
+0.52
(+10.79%)
USD |
NASDAQ |
Sep 24, 16:00
5.34
0.00 (0.00%)
After-Hours: 19:59
NextCure Market Cap : 21.73M for Sept. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 23, 2026 | 19.61M |
| September 22, 2026 | 21.08M |
| September 21, 2026 | 22.22M |
| September 18, 2026 | 24.90M |
| September 17, 2026 | 23.07M |
| September 16, 2026 | 24.54M |
| September 15, 2026 | 25.92M |
| September 14, 2026 | 27.02M |
| September 11, 2026 | 28.48M |
| September 10, 2026 | 29.74M |
| September 09, 2026 | 32.84M |
| September 08, 2026 | 34.26M |
| September 04, 2026 | 31.82M |
| September 03, 2026 | 31.90M |
| September 02, 2026 | 29.91M |
| September 01, 2026 | 27.67M |
| August 31, 2026 | 26.00M |
| August 28, 2026 | 24.78M |
| August 27, 2026 | 24.56M |
| August 26, 2026 | 23.72M |
| August 25, 2026 | 24.05M |
| August 24, 2026 | 23.97M |
| August 21, 2026 | 25.59M |
| August 20, 2026 | 25.43M |
| August 19, 2026 | 27.59M |
| Date | Value |
|---|---|
| August 18, 2026 | 27.06M |
| August 17, 2026 | 31.37M |
| August 14, 2026 | 33.41M |
| August 13, 2026 | 33.69M |
| August 12, 2026 | 33.24M |
| August 11, 2026 | 27.38M |
| August 10, 2026 | 27.83M |
| August 07, 2026 | 23.76M |
| August 06, 2026 | 22.75M |
| August 05, 2026 | 21.36M |
| August 04, 2026 | 23.52M |
| August 03, 2026 | 15.87M |
| July 31, 2026 | 14.95M |
| July 30, 2026 | 18.15M |
| July 29, 2026 | 18.11M |
| July 28, 2026 | 19.55M |
| July 27, 2026 | 18.47M |
| July 24, 2026 | 15.30M |
| July 23, 2026 | 15.08M |
| July 22, 2026 | 15.87M |
| July 21, 2026 | 18.43M |
| July 20, 2026 | 19.48M |
| July 17, 2026 | 21.61M |
| July 16, 2026 | 22.26M |
| July 15, 2026 | 23.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.326B |
| Oncolytics Biotech, Inc. | 83.54M |
| Sangamo Therapeutics, Inc. | 61.56M |
| Sarepta Therapeutics, Inc. | 1.941B |
| Anixa Biosciences, Inc. | 96.14M |
Market Cap Related Metrics
| Price to Book Value | 1.788 |
| Price | 5.34 |
| Earnings Yield | -198.3% |